We compared the efficacy of magnesium sulphate, lignocaine, sodium bicarbonate or alfentanil in minimizing pain due to injection of rocuronium in 250 patients. After tourniquet application on the forearm, the patients were given saline, magnesium sulphate, lignocaine, sodium bicarbonate 8.4% or alfentanil, diluted into a 3 ml solution. The occlusion was released after 20 seconds, and rocuronium was injected over 10 to 15 seconds. The patients were observed and asked immediately if they had pain in the arm and the response was assessed. Reactions such as discomfort and pain, withdrawal of the hand and screaming after the administering of the rocuronium were recorded as side-effects and patients were reassessed at 24 hours postoperatively. We concluded that magnesium sulphate, lignocaine, sodium bicarbonate or alfentanil decreased the level of rocuronium injection pain. Of these drugs, magnesium sulphate, lignocaine and sodium bicarbonate were the most effective while alfentanil was the least effective.
The incidence of pain on injection of rocuronium is frequent; reports suggest that 50 to 80% of patients suffer pain 1 . Althought this compound is considered to be tolerated well during injection, severe burning can occur after IV injection of rocuronium [2] [3] [4] . Rocuronium is supplied as an isotonic solution with a pH of 4. Injection pain is probably caused by the effect of the acidic pH of rocuronium 5, 6 . Even if unconsciousness is rendered before muscle relaxants are administered, it has been demonstrated that patients moved their extremities because of pain, generalized movements in more than one extremity, coughing and breath-holding are seen due to pain on injection 7 . When priming and timing techniques are used for accelerating intubation when rapid intubation is required, precautions must be taken for rocuronium injection pain in awake patients.
Parenteral magnesium has been used for many years on an empirical basis as an antidysrhythmic, for eclampsia and for intra-and postoperative analgesia [8] [9] [10] . Because of its numerous actions, magnesium is called nature's physiologic calcium channel blocker 9 . Calcium channel blockers have shown antinociceptive effects in animals and morphine potentiation in patients with chronic pain [10] [11] [12] . Magnesium also antagonizes the N-methyl-D-aspartate (NMDA) receptor and its associated ion channels 13 . It has been suggested that substances with calcium channel blocking effects and NMDA antagonist action may play a role in prevention of pain and treatment of established pain states 14, 15 . In a recent study, magnesium sulphate has been found to be effective in relieving injection pain caused by propofol 16 .
Sodium bicarbonate has been used to decrease the injection pain of intradermal lignocaine by neutralizing the pH of the drug 17, 18 . Pretreatment with sodium bicarbonate may neutralize the acidic pH of rocuronium thus decreasing the injection pain.
Several studies have tried to determine the concentration of lignocaine that most efficiently diminishes or eliminates pain from propofol and rocuronium injection 2, 4, 5 . Lignocaine was found to be effective in reducing this injection pain. Alfentanil 1 mg has been found as effective as lignocaine in reducing the pain on propofol injection, and the authors speculated on the mechanisms of action 19 .
The aim of this study was to determine the incidence of pain caused by rocuronium injection and to compare the efficacy of magnesium sulphate, lignocaine, sodium bicarbonate and alfentanil in minimizing the pain due to injection of rocuronium.
MATERIAL AND METHODS
After our institutional ethics committee approval and obtaining patients' written informed consent, the study was conducted on 250 patients from ASA 1 and 2 groups who were to undergo various elective operations. Patients with opioid and local anaesthetic allergies, Parkinson's disease, and/or weak, thin dorsal veins were excluded from the study.
The patients included in the study were randomly assigned to five groups. The study was designed to be randomized and double-blinded. A randomization list was generated by computer and identical syringes containing each drug were prepared by an anaesthetist blinded to the study. No premedication was given. The patients were then taken into the operation room where the backs of both hands were cannulated with a 20 gauge cannula and the mean arterial pressure, oxygen saturation (SpO 2 ) and heart rate were monitored. With the aim of keeping the drug within the vein, the forearm was squeezed with a tourniquet up to 70 mmHg, and the patients were administered saline (3 ml) (Group C) (n=50), 2.48 mmol (2 ml) magnesium sulphate (Group M) (n=50), lignocaine 30 mg (Group L) (n=50), 8.4% (2 ml) sodium bicarbonate (Group N) (n=50), or alfentanil 1000 µg (Group A) (n=50), diluted into 3 ml with saline at ambient operating room temperature (20-22°C). All the test solutions were 3 ml. The occlusion was released after 20 seconds and a tracheal intubating dose of 0.6 mg.kg -1 rocuronium at room temperature was injected over 10 to 15 seconds. The patients were observed and asked immediately if they had pain in the arm and the response was assessed. Reactions such as discomfort and pain, tears in the eye, withdrawal of the hand, screaming etc after the administration of the rocuronium were recorded as side-effects 19 (Table 1) . Thirty seconds after administration of rocuronium, 5 mg.kg -1 , thiopentone was administered IV. For the crystalloid infusion and other medication, the IV catheter in the alternate hand was used, not the study hand. Anaesthesia was continued using 50% N 2 O/O 2 and sevoflurane anaesthesia. Patients were asked 24 hours after recovery from anaesthesia whether they had recall of pain, arm movements, heavy eyelids, blurred vision, or difficulty in swallowing and breathing during induction of anaesthesia. Within the first 24 hours after operation, the injection site was checked by an anaesthesiologist who did not know which drug was administered, for any complications such as pain, swelling or allergic reactions.
In the statistical analysis, one-way ANOVA was used for the demographic data. The global association between the rows and columns were determined by log-linear analysis. For pain scores, appropriate Chi-square testing was used for paired comparison of groups. P<0.05 was taken as statistically significant.
RESULTS
No significant differences were found in terms of demographic criteria (Table 2) .
Global association between pain scores (0, 1, 2, 3) and groups (C, M, L, N, A) were analysed by using log-linear analysis. Also, we used correspondence analysis for which categories are related. When we investigated global association between groups and pain scores, significant differences were found for pain scores in group C when compared with the other groups (0: Z=-2.95, P<0.01; 1: Z=-2.26, P<0.05). This is the result of difference of pain intensity. According to results, we found the most effective drugs to be lignocaine and magnesium. No statistical difference was found between groups.
Paired comparison of groups for pain scores and statistically evaluated determined differences can be seen in Table 3 . Magnesium sulphate, lignocaine, sodium bicarbonate and alfentanil prevent or decrease the degree of rocuronium injection pain. We found the most effective drugs to be magnesium sulphate, sodium bicarbonate and lignocaine, with alfentanil least effective.
In group M, five patients reported a pain score of 1 on injection of magnesium sulphate which did not require treatment and subsided in a few seconds without any intervention. Patients in other groups did not report any pain on injection of the study drugs. When compared with other groups this was found to be statistically significant (P<0.05). Four patients in the control group recalled pain or movements in this arm during induction of anaesthesia while three patients recalled pain on injection of magnesium. No patient reported heavy eyelids or blurred vision, difficulty in swallowing and breathing.
No side-effects were observed within the first 24 hours.
DISCUSSION
There are reports describing the burning pain associated with administration of rocuronium before induction of anaesthesia [1] [2] [3] 20 . The incidence of pain on injection from rocuronium is frequent enough for action to be taken. Reports suggest that 50 to 80% of patients suffer pain 1 .
Klement and Arndt 21 showed that acidic and alkaline solutions elicited pain at pH values of less than 4 and more than 11 respectively. Pain on intravenous injection of some sedative and hypnotic drugs is likely to be caused by formulations of extremely unphysiological osmolalities or pH values. Rocuronium is an isotonic solution with a pH of 4. Injection pain is probably caused by the effect of the acidic pH of rocuronium 5 . It has also been demonstrated that inflammatory mediators potentiate the algogenic effect of low pH of drugs. In our study we have also demonstrated that administration of rocuronium is associated with pain. The different pretreatment drugs were compared with magnesium sulphate, lignocaine and sodium bicarbonate the most effective in reducing pain whilst alfentanil was less effective.
Venous retention with a tourniquet is a technique often used for pretreatment of propofol injection pain to keep the study drug in the vein longer. We also used this technique.
The mechanism of analgesic effect of magnesium is not clear, but interference with calcium channels 9, 11 and NMDA receptors seem to play an important role [13] [14] [15] . The analgesic action of calcium channel blockers could be mediated by an increase of the nociceptive threshold resulting from interference with calcium influx because the latter is important for the release of neurotransmitters and other substances implicated in nociception and inflammation.
Some studies have reported that magnesium has an endothelium-derived nitric oxide -induced vasodilatory effect 22, 23 . Nitric oxide causes activation of guanyl cyclase and an increase in cyclic guanine monophosphate, which mediates the relaxation of vascular smooth muscles 24, 25 . Nitric oxide is also a potent inhibitor of neutrophil adhesion to vascular endothelium 24 . Nitric oxide donors have also been shown to protect vascular endothelium from ischaemia and reperfusion-mediated endothelial dysfunction 24 . Nitric oxide is also a potent inhibitor of platelet adhesion to endothelial surfaces 24 . Magnesium might decrease rocuronium injection pain by this mechanism. In a study performed in our clinic, magnesium has been shown to decrease propofol injection pain 16 .
Lockey and Coleman 2 reported marked discomfort in all patients who received 0.6 mg.kg -1 rocuronium IV immediately after an induction dose of propofol mixed with lignocaine 20 mg, which seemed to be unrelated to the discomfort from propofol. Cheong and Wong 5 evaluated whether prior administration of lignocaine 10 mg or 30 mg IV decreased the incidence of injection pain. They found that both lignocaine 10 mg and 30 mg IV given before administration of rocuronium significantly reduced the incidence and severity of pain from injection of rocuronium, and the larger dose was more effective.
Sodium bicarbonate, by neutralization of acidic drugs, reduced injection discomfort in patients 17 7) is a simple method for less painful application of local anaesthesia. In our study we found sodium bicarbonate to effectively reduce pain caused by rocuronium injection. This may demonstrate that rocuronium injection pain is caused by the acidic pH of 4.0. Alfentanil 1 mg was found as effective as lignocaine in reducing pain on propofol injection, and mechanisms of action were postulated 19 . Fletcher et al 27 also demonstrated that pretreatment with alfentanil reduced pain caused by propofol. In our study we have demonstrated that alfentanil pretreatment was effective when compared with placebo but had a limited effect when compared with the other pretreatment methods.
Giving muscle relaxants before an anaesthetic agent can be unpleasant for the patient, causing heavy eyelids, blurred vision, or difficulty in swallowing and breathing 28 , but in our study no patient reported these side-effects.
In a study in our clinic 29 , we compared the efficacy of ondansetron, lignocaine, tramadol and fentanyl in minimizing pain caused by injection of rocuronium and determined that ondansetron, lignocaine, tramadol, and fentanyl decrease the level of rocuronium injection pain. Among these drugs, lignocaine was found to be the most effective, whereas fentanyl was the least effective. When we evaluate the results from both studies, rocuronium injection causes considerable pain and different pretreatment drugs can be used to decrease the associated pain. Lignocaine seems to be the best in preventing rocuronium injection pain. This is the first clinical study showing that magnesium sulphate, sodium bicarbonate and alfentanil may be useful in the prevention of rocuronium injection pain. However, before applying the results of this study into clinical anaesthesia practice, the possible side-effects of magnesium administration should be considered including minimal pain caused by injection.
We conclude that rocuronium injection causes significant pain, and magnesium sulphate, lignocaine and sodium bicarbonate were effective in decreasing the level of rocuronium injection pain, with alfentanil less so but still better than saline placebo.
